The patient was admitted on [**8-/2186**] and found to have D-differential papillary carcinoma on fine-needle aspiration.
The patient was scheduled for total thyroidectomy with the surgery team on [**9-29**] with plan to pursue adjuvant chemotherapy and XRT to the surgical bed.
The patient was to receive carboplatinum and Taxol as the chemotherapeutic regimen.
The patient was started on decadron prechemotherapy and the course was complicated by possible pneumonia on chest x-ray.
Uniretic 25/15 q.d.
MEDICATIONS ON TRANSFER:  Medications upon transfer to the medicine service were as follows: 1.
Tums 500 mg t.i.d.
Albuterol nebs q.6 hours p.r.n.
Levofloxacin 500 mg q.d.
Levoxyl 100 mg q.d.
Lopressor 50 mg b.i.d.
Protonix 40 mg q.d.
Morphine IV q.4h.
Albuterol and Atrovent MDIs.
HOSPITAL COURSE:  The patient was admitted to the Surgical Service, where she had a resection of the thyroid and she was transferred to the medical service for administration of chemotherapy and further medical management.
nebs, Albuterol and Atrovent MDIs and Flovent MDIs, as well as aggressive chest PT.
The patient was also placed Levaquin and Flagyl due to possible pneumonia given low-grade temperatures, increased white blood cell count and a chest x-ray, which was equivocable for lower lobe atelectasis versus pneumonia.
The patient was also placed on a rapid Prednisone taper to increase the pulmonary reserves, as well.
ONCOLOGY:  The patient was administered Taxol and Carboplatin with premedication on [**10-6**] with XRT to be followed up in three weeks.
The patient tolerated this regimen fairly well, even though she had subsequent decrease in the hematocrit possibly due to this chemotherapy.
From the hematologic standpoint, the patient was converted from coumadin to low-molecular weight heparin with good therapeutic effect for her PEs.
The patient had guaiac time three negative and hemolysis labs, which were negative, but the hematocrit continued to drift downwards and eventually had to be transfused two units of packed red blood cells.
Of note, the patient is not a Jehovah Witness, but she was raised in the Jehovah Witness family and held off for transfusion until her hematocrit reached 22.
The patient was also started on q. week Procrit and iron as well.
The patient, at the time of discharge, had decreased PO intake of solid foods and remained in fluid restriction.
From an endocrine standpoint, the patient remained on her regular insulin sliding scale, which was adequate, even though while she was on her Prednisone taper, the glucose levels ran consistently around 150 to 170.
The patient's family members were also present during her conversations and agreed with the plan.
Lovenox 70 mg subcutaneously q.12h.
Protonix 40 mg PO/IV q.d.
Colace 100 mg PO b.i.d.
Albuterol two puffs MDI q.4h.
Levoxyl 100 mcg PO q.d.
Tums 500 mg PO t.i.d.
Lopressor 50 mg PO b.i.d.
Trazodone 50 mg PO q.h.s.p.r.n.
Flagyl 500 mg PO t.i.d.
Levaquin 500 mg PO q.d.
Prednisone 40 mg q.d.
Flovent 110 mcg MDI four puffs b.i.d.
Albuterol and Atrovent nebulizers q.4h.
Lasix 20 mg PO q.d.
Ferrous sulfate 325 mg PO t.i.d.
Procrit 40,000 units q.week.
Dulcolax 10 mg PO p.r.n.q.d.
Sodium chloride one gram PO b.i.d.
Ibuprofen 600 mg q.4h.p.r.n.
Zofran 8 mg IV q.8h.p.r.n.
Robitussin p.r.n.
The patient was to be discharged to [**Hospital3 7**] for further management of her pulmonary complications secondary to pulmonary metastasis.
The patient was to follow up with her hematologist/oncologist, Dr. [**Last Name (STitle) 4711**] next Tuesday at which time it would be reconsidered if she needed further chemotherapeutic interventions, as well as XRT.
